Market Tracker

08/01 9:53am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.78
Data as of 9:38am ET
 +0.0399 / +0.41%
Today’s Change
6.51
Today|||52-Week Range
18.18
-34.76%
Year-to-Date

Today’s Trading

Previous close9.74
Today’s open9.85
Day’s range9.61 - 9.87
Volume147,473
Average volume (3 months)1,836,004
Market cap$1.2B
Dividend yield--
Data as of 9:38am ET, 08/01/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.90%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp-1.25-3.20%
NVAXNovavax Inc+0.01+0.23%
AEGRAegerion Pharmaceuti...+0.39+1.16%
BLUEbluebird bio Inc+0.23+0.69%
Data as of 9:51am ET, 08/01/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts